Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
2002 · Medicinal Research Reviews · 333 citations
https://doi.org/10.1002/med.10011
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
209
Papers
4.1K
Citations
31
h-index
77
i10-index
Mercedes Alonso is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Crystallization and Solubility Studies & X-ray Diffraction in Crystallography & Synthesis and Properties of Aromatic Compounds. The author has an h-index of 31, co-authored 178 publications.
ORCID: 0000-0002-7076-2305https://doi.org/10.1002/med.10011
https://doi.org/10.1007/s11244-021-01480-7
Click to start Chat